Phosphoglycerate kinase

A hinge-bending enzyme

Research output: Book

Abstract

Phosphoglycerate kinase (PGK) is an essential metabolic enzyme for all living organisms. It catalyses the high-energy phospho-transfer reaction from 1,3-bisphosphoglycerate to the beta-phosphate of ADP and thereby produces ATP. In mammals, PGK has more widespread roles, particularly in oncogenesis and in activating anti-retroviral drugs. Namely, PGK exhibits specific thiol-reductase activity important in the inhibition of plasmin-mediated angiogenesis required for solid tumour development. The phosphorylating activity of PGK, however, has been additionally proved to be involved in specific activation of antiviral and antitumour nucleotide-analogue drugs. In addition, the simple two-domain structure of PGK has served as a good folding-model of multidomain proteins. From folding-studies, not only the possible role of domains in the self-organisation process has been exemplified, but characteristics of the sophisticated protein misfolding mechanism has also been described. Besides the pathological anatomy (misfolding), the pathological physiology (misfunction) of PGK is also overviewed. Human phosphoglycerate kinase mutations have been identified to be associated with various serious diseases, such as mild to severe haemolytic anaemia, neurological disorders, mental retardation, behavioural aberrations, and neurological symptoms. These aspects are also discussed and summarized in this volume.

Original languageEnglish
PublisherNova Science Publishers, Inc.
Number of pages292
ISBN (Print)9781628088380, 9781628088366
Publication statusPublished - jan. 1 2013

Fingerprint

Phosphoglycerate Kinase
Enzymes
Fibrinolysin
Hemolytic Anemia
Energy Transfer
Nervous System Diseases
Sulfhydryl Compounds
Intellectual Disability
Pharmaceutical Preparations
Adenosine Diphosphate
Antiviral Agents
Mammals
Anatomy
Oxidoreductases
Carcinogenesis
Proteins
Nucleotides
Adenosine Triphosphate
Phosphates
Mutation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Vas, M. (2013). Phosphoglycerate kinase: A hinge-bending enzyme. Nova Science Publishers, Inc.

Phosphoglycerate kinase : A hinge-bending enzyme. / Vas, M.

Nova Science Publishers, Inc., 2013. 292 p.

Research output: Book

Vas, M 2013, Phosphoglycerate kinase: A hinge-bending enzyme. Nova Science Publishers, Inc.
Vas M. Phosphoglycerate kinase: A hinge-bending enzyme. Nova Science Publishers, Inc., 2013. 292 p.
Vas, M. / Phosphoglycerate kinase : A hinge-bending enzyme. Nova Science Publishers, Inc., 2013. 292 p.
@book{e6c3bcad6ab940a7b1e2b5f1b989bfb6,
title = "Phosphoglycerate kinase: A hinge-bending enzyme",
abstract = "Phosphoglycerate kinase (PGK) is an essential metabolic enzyme for all living organisms. It catalyses the high-energy phospho-transfer reaction from 1,3-bisphosphoglycerate to the beta-phosphate of ADP and thereby produces ATP. In mammals, PGK has more widespread roles, particularly in oncogenesis and in activating anti-retroviral drugs. Namely, PGK exhibits specific thiol-reductase activity important in the inhibition of plasmin-mediated angiogenesis required for solid tumour development. The phosphorylating activity of PGK, however, has been additionally proved to be involved in specific activation of antiviral and antitumour nucleotide-analogue drugs. In addition, the simple two-domain structure of PGK has served as a good folding-model of multidomain proteins. From folding-studies, not only the possible role of domains in the self-organisation process has been exemplified, but characteristics of the sophisticated protein misfolding mechanism has also been described. Besides the pathological anatomy (misfolding), the pathological physiology (misfunction) of PGK is also overviewed. Human phosphoglycerate kinase mutations have been identified to be associated with various serious diseases, such as mild to severe haemolytic anaemia, neurological disorders, mental retardation, behavioural aberrations, and neurological symptoms. These aspects are also discussed and summarized in this volume.",
author = "M. Vas",
year = "2013",
month = "1",
day = "1",
language = "English",
isbn = "9781628088380",
publisher = "Nova Science Publishers, Inc.",

}

TY - BOOK

T1 - Phosphoglycerate kinase

T2 - A hinge-bending enzyme

AU - Vas, M.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Phosphoglycerate kinase (PGK) is an essential metabolic enzyme for all living organisms. It catalyses the high-energy phospho-transfer reaction from 1,3-bisphosphoglycerate to the beta-phosphate of ADP and thereby produces ATP. In mammals, PGK has more widespread roles, particularly in oncogenesis and in activating anti-retroviral drugs. Namely, PGK exhibits specific thiol-reductase activity important in the inhibition of plasmin-mediated angiogenesis required for solid tumour development. The phosphorylating activity of PGK, however, has been additionally proved to be involved in specific activation of antiviral and antitumour nucleotide-analogue drugs. In addition, the simple two-domain structure of PGK has served as a good folding-model of multidomain proteins. From folding-studies, not only the possible role of domains in the self-organisation process has been exemplified, but characteristics of the sophisticated protein misfolding mechanism has also been described. Besides the pathological anatomy (misfolding), the pathological physiology (misfunction) of PGK is also overviewed. Human phosphoglycerate kinase mutations have been identified to be associated with various serious diseases, such as mild to severe haemolytic anaemia, neurological disorders, mental retardation, behavioural aberrations, and neurological symptoms. These aspects are also discussed and summarized in this volume.

AB - Phosphoglycerate kinase (PGK) is an essential metabolic enzyme for all living organisms. It catalyses the high-energy phospho-transfer reaction from 1,3-bisphosphoglycerate to the beta-phosphate of ADP and thereby produces ATP. In mammals, PGK has more widespread roles, particularly in oncogenesis and in activating anti-retroviral drugs. Namely, PGK exhibits specific thiol-reductase activity important in the inhibition of plasmin-mediated angiogenesis required for solid tumour development. The phosphorylating activity of PGK, however, has been additionally proved to be involved in specific activation of antiviral and antitumour nucleotide-analogue drugs. In addition, the simple two-domain structure of PGK has served as a good folding-model of multidomain proteins. From folding-studies, not only the possible role of domains in the self-organisation process has been exemplified, but characteristics of the sophisticated protein misfolding mechanism has also been described. Besides the pathological anatomy (misfolding), the pathological physiology (misfunction) of PGK is also overviewed. Human phosphoglycerate kinase mutations have been identified to be associated with various serious diseases, such as mild to severe haemolytic anaemia, neurological disorders, mental retardation, behavioural aberrations, and neurological symptoms. These aspects are also discussed and summarized in this volume.

UR - http://www.scopus.com/inward/record.url?scp=84951751439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951751439&partnerID=8YFLogxK

M3 - Book

SN - 9781628088380

SN - 9781628088366

BT - Phosphoglycerate kinase

PB - Nova Science Publishers, Inc.

ER -